Viewing Study NCT03609593


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2026-02-24 @ 12:14 AM
Study NCT ID: NCT03609593
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-07
First Post: 2018-07-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine/rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Sponsor: Nicole Lamanna
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module